Key Biomarkers Deep Dive

Fasting insulin is arguably the single most important biomarker for health optimization, yet most standard medical panels do not include it. The conventional reference range (2-19 uIU/mL) is based on a population average that includes millions of metabolically unhealthy individuals. Optimal fasting insulin is below 5 uIU/mL. Between 5-7 is early insulin resistance. Above 7 is clinically significant insulin resistance, even if fasting glucose is still "normal." HOMA-IR, calculated as (fasting insulin x fasting glucose) / 405, should be below 1.0 for optimal metabolic health. This single biomarker tells you more about Root Cause 2 than any other test.

Inflammatory biomarkers reveal the status of Root Cause 1. High-sensitivity CRP (hs-CRP) should be below 0.5 mg/L for optimal health (the "normal" reference range of below 3.0 includes many chronically inflamed individuals). Homocysteine, a marker of methylation status and cardiovascular inflammation, should be between 6-8 umol/L. ESR (erythrocyte sedimentation rate) provides another window into systemic inflammation. Ferritin can indicate both iron status and inflammation (it is an acute phase reactant that rises with inflammation). For a comprehensive inflammatory picture, also consider IL-6 and TNF-alpha, though these are more specialized and expensive tests.

IGF-1 is the key marker for GH secretagogue protocols. Baseline IGF-1 establishes your current GH status. During a GH protocol, IGF-1 should rise into the upper third of the age-adjusted reference range (approximately 200-300 ng/mL for most adults). If IGF-1 rises above this range, reduce the GH secretagogue dose. Persistently elevated IGF-1 (above 350 ng/mL) is associated with increased cancer risk in some studies and should be avoided. For longevity protocols, aim for a moderate IGF-1 level that balances the anabolic and repair benefits of GH against the theoretical cancer risk of sustained high levels.